Opioid Painkillers Under Attack Opioid based pain drugs have dominated the pain relief marketplace for years but their dominance has more reflected a lack of other options than anything else. They’re quite effective at reducing acute pain but not so good at with...
Citing statistics indicating that 40 people die every day in the U.S. from prescription pain killer overdose, CDC director Tom Frieden bluntly called for doctors to stop over prescribing the drugs. The CDC’s voluntary guidelines called for opioid pain killers...
With an enormous potential therapeutic gain and a high safety profile, further development and application of VNS is encouraging. Yuan et. Al Vagus nerve stimulation is one of the most promising chronic pain interventions under development today. An earlier blog on...
Forget the drugs – how about putting your hand in a machine and watching the pain ebb away? Science fiction? One company thinks not – and it’s recent Phase II study has turned out quite well – thank you. The Avacen machine purports to reduce...
Effective pain management is a moral imperative – one we are not meeting. An IOM report Pain management is dominated by the use of opiates but arguably it shouldn’t be. Producing a sensation of pain is a complex operation. From the pain signals produced at...
Milnacipran (brand names: Savella, Ixel) is the third and last drug the FDA approved for the treatment of fibromyalgia in the United States. The fourth serotonin–norepinephrine reuptake inhibitor (SNRI), to be introduced in the U.S., Savella stops the reuptake of...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.